DermTech Appoints Mark Aguillard as Chief Commercial Officer
DermTech, Inc. (NASDAQ: DMTK) (DermTech or the Company), a leader in precision dermatology enabled by a non-invasive skin genomics technology, today announced the appointment of Mark Aguillard as chief commercial officer effective September 19, 2023.
- DermTech, Inc. (NASDAQ: DMTK) (DermTech or the Company), a leader in precision dermatology enabled by a non-invasive skin genomics technology, today announced the appointment of Mark Aguillard as chief commercial officer effective September 19, 2023.
- Mr. Aguillard will lead DermTech’s overall commercial strategy and execution.
- Commenting on Mr. Aguillard’s appointment, Bret Christensen, DermTech’s CEO said, “I’d like to welcome Mark to the team.
- Mr. Aguillard received his Bachelor’s in Business Administration with a major in Finance from Texas Tech University.